Green Thumb Industries posted $306.7 million in second-quarter revenue, $4.9 million in GAAP net income and $29 million in operating cash flow. Motley Fool says shares near $8 may still look inexpensive, though gross margin and comparable retail sales declined.
Revenue rose 4.6% year over year, while gross margin fell to 45% from 49.9% a year earlier, largely because of licensing fees and continued price compression; comparable retail sales dropped 1.1%. The company ended June with $283.6 million in cash against $283 million in debt and reported $84.3 million in normalized EBITDA for the quarter.
Green Thumb repurchased the equivalent of 7.9 million subordinate voting shares for $48.3 million in Q2. Since starting its buyback program, it has repurchased about 29.5 million shares for $203.4 million, averaging $6.90 per share. The company also operates six RISE dispensaries and a cultivation and processing facility in Virginia, where recreational sales are scheduled to begin July 1, 2027.
